

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 9.41749662 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 9.41749662 |
| 3 | fatty acid elongation (GO:0030497) | 7.18519458 |
| 4 | positive regulation of chemokine secretion (GO:0090197) | 5.77887823 |
| 5 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.43566708 |
| 6 | regulation of chemokine secretion (GO:0090196) | 5.34987246 |
| 7 | ensheathment of neurons (GO:0007272) | 5.08746162 |
| 8 | axon ensheathment (GO:0008366) | 5.08746162 |
| 9 | myelination (GO:0042552) | 5.07386539 |
| 10 | negative regulation of complement activation (GO:0045916) | 4.91373532 |
| 11 | negative regulation of protein activation cascade (GO:2000258) | 4.52802738 |
| 12 | hepatocyte apoptotic process (GO:0097284) | 4.49819255 |
| 13 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.49119948 |
| 14 | cholesterol biosynthetic process (GO:0006695) | 4.46113462 |
| 15 | positive regulation of macrophage activation (GO:0043032) | 4.38976060 |
| 16 | iron ion import (GO:0097286) | 4.27429217 |
| 17 | negative regulation of neurotransmitter transport (GO:0051589) | 4.23086537 |
| 18 | endocrine hormone secretion (GO:0060986) | 4.20885879 |
| 19 | amyloid precursor protein metabolic process (GO:0042982) | 4.09186849 |
| 20 | sterol biosynthetic process (GO:0016126) | 4.00962278 |
| 21 | negative regulation of humoral immune response (GO:0002921) | 3.94472412 |
| 22 | myelin maintenance (GO:0043217) | 3.91417099 |
| 23 | isoprenoid biosynthetic process (GO:0008299) | 3.86615069 |
| 24 | detection of molecule of bacterial origin (GO:0032490) | 3.84130542 |
| 25 | adhesion of symbiont to host cell (GO:0044650) | 3.81722526 |
| 26 | virion attachment to host cell (GO:0019062) | 3.81722526 |
| 27 | protein neddylation (GO:0045116) | 3.81248590 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.77488721 |
| 29 | amyloid precursor protein catabolic process (GO:0042987) | 3.70995808 |
| 30 | regulation of interleukin-5 production (GO:0032674) | 3.70377366 |
| 31 | mesodermal cell differentiation (GO:0048333) | 3.66218568 |
| 32 | nucleotide transmembrane transport (GO:1901679) | 3.65125737 |
| 33 | regulation of collateral sprouting (GO:0048670) | 3.61613537 |
| 34 | negative regulation of protein localization to cell surface (GO:2000009) | 3.55579430 |
| 35 | glycerophospholipid catabolic process (GO:0046475) | 3.52301526 |
| 36 | oligodendrocyte differentiation (GO:0048709) | 3.50183782 |
| 37 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 3.48917977 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.41143122 |
| 39 | GPI anchor biosynthetic process (GO:0006506) | 3.39410949 |
| 40 | signal peptide processing (GO:0006465) | 3.33060486 |
| 41 | glycosylceramide metabolic process (GO:0006677) | 3.32943775 |
| 42 | regulation of lipoprotein metabolic process (GO:0050746) | 3.31420824 |
| 43 | creatine metabolic process (GO:0006600) | 3.29031826 |
| 44 | cellular response to ethanol (GO:0071361) | 3.27658484 |
| 45 | response to redox state (GO:0051775) | 3.27486607 |
| 46 | negative regulation of acute inflammatory response (GO:0002674) | 3.26383373 |
| 47 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 3.22618171 |
| 48 | presynaptic membrane assembly (GO:0097105) | 3.22242752 |
| 49 | import into cell (GO:0098657) | 3.21825321 |
| 50 | photoreceptor cell differentiation (GO:0046530) | 3.18086599 |
| 51 | eye photoreceptor cell differentiation (GO:0001754) | 3.18086599 |
| 52 | response to lipoprotein particle (GO:0055094) | 3.17184484 |
| 53 | intracellular pH reduction (GO:0051452) | 3.13098419 |
| 54 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 3.12608250 |
| 55 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.10873610 |
| 56 | GPI anchor metabolic process (GO:0006505) | 3.09722329 |
| 57 | positive regulation of interleukin-17 production (GO:0032740) | 3.08489081 |
| 58 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.06005918 |
| 59 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 3.03925530 |
| 60 | membrane raft organization (GO:0031579) | 3.03524250 |
| 61 | macrophage activation involved in immune response (GO:0002281) | 3.00695984 |
| 62 | pH reduction (GO:0045851) | 2.98920222 |
| 63 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.98254651 |
| 64 | intestinal epithelial cell development (GO:0060576) | 2.97030474 |
| 65 | regulation of gonadotropin secretion (GO:0032276) | 2.94085201 |
| 66 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.93485871 |
| 67 | positive regulation by symbiont of host defense response (GO:0052509) | 2.92915933 |
| 68 | modulation by symbiont of host defense response (GO:0052031) | 2.92915933 |
| 69 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.92915933 |
| 70 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.92915933 |
| 71 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.92915933 |
| 72 | modulation by symbiont of host immune response (GO:0052553) | 2.92915933 |
| 73 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.91626561 |
| 74 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.91626561 |
| 75 | negative regulation of interferon-gamma production (GO:0032689) | 2.88799282 |
| 76 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.88077153 |
| 77 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85754250 |
| 78 | adhesion of symbiont to host (GO:0044406) | 2.84264600 |
| 79 | mannosylation (GO:0097502) | 2.83565309 |
| 80 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.83136921 |
| 81 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.81889243 |
| 82 | lung vasculature development (GO:0060426) | 2.80844265 |
| 83 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 2.79818312 |
| 84 | cell adhesion mediated by integrin (GO:0033627) | 2.79212787 |
| 85 | very long-chain fatty acid metabolic process (GO:0000038) | 2.77986272 |
| 86 | astrocyte development (GO:0014002) | 2.77839003 |
| 87 | macrophage activation (GO:0042116) | 2.77343872 |
| 88 | cellular extravasation (GO:0045123) | 2.77009815 |
| 89 | L-amino acid import (GO:0043092) | 2.76305002 |
| 90 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.76231968 |
| 91 | negative regulation of chemokine production (GO:0032682) | 2.75213433 |
| 92 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.74195268 |
| 93 | positive regulation of interferon-alpha production (GO:0032727) | 2.73524801 |
| 94 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.72026931 |
| 95 | magnesium ion transport (GO:0015693) | 2.70575702 |
| 96 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.70552388 |
| 97 | apical protein localization (GO:0045176) | 2.69703567 |
| 98 | substantia nigra development (GO:0021762) | 2.68886116 |
| 99 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.68710568 |
| 100 | response to methylmercury (GO:0051597) | 2.67103900 |
| 101 | response to peptidoglycan (GO:0032494) | 2.66301649 |
| 102 | negative regulation of JUN kinase activity (GO:0043508) | 2.65529570 |
| 103 | asymmetric protein localization (GO:0008105) | 2.63553095 |
| 104 | regulation of T-helper 1 type immune response (GO:0002825) | 2.62812000 |
| 105 | establishment of protein localization to Golgi (GO:0072600) | 2.62806503 |
| 106 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.62365541 |
| 107 | positive regulation of macrophage differentiation (GO:0045651) | 2.61883192 |
| 108 | positive regulation of tyrosine phosphorylation of Stat3 protein (GO:0042517) | 2.60509072 |
| 109 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.60254251 |
| 110 | L-phenylalanine catabolic process (GO:0006559) | 2.60254251 |
| 111 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.59134893 |
| 112 | positive regulation of pseudopodium assembly (GO:0031274) | 2.59134103 |
| 113 | glutathione derivative biosynthetic process (GO:1901687) | 2.58690837 |
| 114 | glutathione derivative metabolic process (GO:1901685) | 2.58690837 |
| 115 | regulation of macrophage differentiation (GO:0045649) | 2.58615423 |
| 116 | fibroblast migration (GO:0010761) | 2.56825812 |
| 117 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.56202647 |
| 118 | nucleotide transport (GO:0006862) | 2.54452926 |
| 119 | negative regulation of macrophage differentiation (GO:0045650) | 2.54122240 |
| 120 | regulation of interferon-alpha production (GO:0032647) | 2.54047537 |
| 121 | regulation of macrophage activation (GO:0043030) | 2.53820909 |
| 122 | glutathione biosynthetic process (GO:0006750) | 2.53274924 |
| 123 | heme transport (GO:0015886) | 2.53227741 |
| 124 | definitive hemopoiesis (GO:0060216) | 2.53108623 |
| 125 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.52608879 |
| 126 | autophagic vacuole fusion (GO:0000046) | 2.51557931 |
| 127 | cellular response to interferon-alpha (GO:0035457) | 2.50913602 |
| 128 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.50262397 |
| 129 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.50200347 |
| 130 | eyelid development in camera-type eye (GO:0061029) | 2.50078431 |
| 131 | positive regulation of chemokine production (GO:0032722) | 2.49641907 |
| 132 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.47689528 |
| 133 | T-helper 1 type immune response (GO:0042088) | 2.47257714 |
| 134 | estrogen biosynthetic process (GO:0006703) | 2.46912205 |
| 135 | microglial cell activation (GO:0001774) | 2.45759809 |
| 136 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 2.45736459 |
| 137 | endothelial cell chemotaxis (GO:0035767) | 2.45419811 |
| 138 | Rap protein signal transduction (GO:0032486) | 2.45418041 |
| 139 | detection of external biotic stimulus (GO:0098581) | 2.44202029 |
| 140 | interferon-gamma secretion (GO:0072643) | 2.44146753 |
| 141 | regulation of establishment of cell polarity (GO:2000114) | 2.42223591 |
| 142 | COPII vesicle coating (GO:0048208) | 2.41387659 |
| 143 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.41295993 |
| 144 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.41032458 |
| 145 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.41007719 |
| 146 | response to host (GO:0075136) | 2.41007719 |
| 147 | response to host defenses (GO:0052200) | 2.41007719 |
| 148 | regulation of T cell migration (GO:2000404) | 2.40693368 |
| 149 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.40540509 |
| 150 | response to interferon-alpha (GO:0035455) | 2.40135215 |
| 151 | positive regulation of actin filament depolymerization (GO:0030836) | 2.40001040 |
| 152 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.39844979 |
| 153 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.39303640 |
| 154 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.39201477 |
| 155 | establishment of mitochondrion localization (GO:0051654) | 2.38949046 |
| 156 | estrogen metabolic process (GO:0008210) | 2.38939400 |
| 157 | negative regulation of adaptive immune response (GO:0002820) | 2.38831276 |
| 158 | ear development (GO:0043583) | 2.38692418 |
| 159 | striated muscle atrophy (GO:0014891) | 2.38315399 |
| 160 | response to lead ion (GO:0010288) | 2.38298299 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.37260287 |
| 162 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.37170697 |
| 163 | thioester biosynthetic process (GO:0035384) | 2.36849945 |
| 164 | acyl-CoA biosynthetic process (GO:0071616) | 2.36849945 |
| 165 | protein palmitoylation (GO:0018345) | 2.35979958 |
| 166 | membrane tubulation (GO:0097320) | 2.35971894 |
| 167 | pericardium development (GO:0060039) | 2.35825712 |
| 168 | aldehyde catabolic process (GO:0046185) | 2.35325633 |
| 169 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.35184788 |
| 170 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.35184788 |
| 171 | positive regulation of catenin import into nucleus (GO:0035413) | 2.34783625 |
| 172 | ER overload response (GO:0006983) | 2.34683828 |
| 173 | C-terminal protein lipidation (GO:0006501) | 2.34525280 |
| 174 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.34264905 |
| 175 | negative regulation of protein autophosphorylation (GO:0031953) | 2.34129322 |
| 176 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.34061769 |
| 177 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.33976099 |
| 178 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.32550021 |
| 179 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.30627878 |
| 180 | embryonic process involved in female pregnancy (GO:0060136) | 2.29753169 |
| 181 | wound healing, spreading of epidermal cells (GO:0035313) | 2.29711282 |
| 182 | macroautophagy (GO:0016236) | 2.29579092 |
| 183 | chondrocyte development (GO:0002063) | 2.29100137 |
| 184 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 2.28974938 |
| 185 | regulation of complement activation (GO:0030449) | 2.26586356 |
| 186 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.24247267 |
| 187 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.24247267 |
| 188 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.24247267 |
| 189 | protein targeting to vacuole (GO:0006623) | 2.20312802 |
| 190 | protein targeting to lysosome (GO:0006622) | 2.20312802 |
| 191 | establishment of protein localization to vacuole (GO:0072666) | 2.20312802 |
| 192 | diterpenoid biosynthetic process (GO:0016102) | 2.19613887 |
| 193 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.19564023 |
| 194 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.19294364 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 3.38299044 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.36457229 |
| 3 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.18336807 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.14236561 |
| 5 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.07451913 |
| 6 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 2.89286763 |
| 7 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.88250612 |
| 8 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.87512814 |
| 9 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.73900120 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.71029614 |
| 11 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.47677956 |
| 12 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.47287132 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.45159033 |
| 14 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.31622387 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.28538478 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.23656430 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.22555419 |
| 18 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.22365317 |
| 19 | AHR_22903824_ChIP-Seq_MCF-7_Human | 2.20686127 |
| 20 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.17748018 |
| 21 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 2.15293838 |
| 22 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 2.15293838 |
| 23 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 2.14529457 |
| 24 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 2.14529457 |
| 25 | ER_23166858_ChIP-Seq_MCF-7_Human | 2.06901791 |
| 26 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.03156937 |
| 27 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02985679 |
| 28 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.01367956 |
| 29 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96847487 |
| 30 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.96249090 |
| 31 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.91717468 |
| 32 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.91665532 |
| 33 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.90789912 |
| 34 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.88856101 |
| 35 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.88578474 |
| 36 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.87523293 |
| 37 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.87321404 |
| 38 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.80657647 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.80463144 |
| 40 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.77896770 |
| 41 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.71553151 |
| 42 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69985724 |
| 43 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.68245720 |
| 44 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.68154930 |
| 45 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.67843779 |
| 46 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.67740958 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.65139614 |
| 48 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.64355320 |
| 49 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.64261930 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61577244 |
| 51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60790144 |
| 52 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60410516 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.58498570 |
| 54 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56402831 |
| 55 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.54749849 |
| 56 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.53127034 |
| 57 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.52839792 |
| 58 | VDR_22108803_ChIP-Seq_LS180_Human | 1.50512934 |
| 59 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50501971 |
| 60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47320112 |
| 61 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.45282264 |
| 62 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.45138050 |
| 63 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.43724376 |
| 64 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.42757212 |
| 65 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.40408995 |
| 66 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.39576291 |
| 67 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.39498291 |
| 68 | P300_19829295_ChIP-Seq_ESCs_Human | 1.39071621 |
| 69 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36941982 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.35288476 |
| 71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.35250709 |
| 72 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.32954776 |
| 73 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.31959049 |
| 74 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.31008240 |
| 75 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.30837354 |
| 76 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.30807062 |
| 77 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.27983204 |
| 78 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26071488 |
| 79 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24723093 |
| 80 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.23364917 |
| 81 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22155389 |
| 82 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.21131505 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.20781554 |
| 84 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20198574 |
| 85 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.20123212 |
| 86 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.19858952 |
| 87 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.19282825 |
| 88 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.18731204 |
| 89 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.18617375 |
| 90 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18418012 |
| 91 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.18217500 |
| 92 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.18017506 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.17519338 |
| 94 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.17390321 |
| 95 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17052877 |
| 96 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.16502126 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.15768946 |
| 98 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.15083502 |
| 99 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.15036792 |
| 100 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.14917613 |
| 101 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.13840072 |
| 102 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.13455500 |
| 103 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.12986191 |
| 104 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.11226485 |
| 105 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10947895 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10181312 |
| 107 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.09733118 |
| 108 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.09414682 |
| 109 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.09232527 |
| 110 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.09106604 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08025723 |
| 112 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.08015275 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.07558244 |
| 114 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.07401177 |
| 115 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.07112605 |
| 116 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06175143 |
| 117 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05963814 |
| 118 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.05842481 |
| 119 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05790578 |
| 120 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05595379 |
| 121 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.05485199 |
| 122 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.05142597 |
| 123 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.04774654 |
| 124 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.04655017 |
| 125 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.04465119 |
| 126 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02760630 |
| 127 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02760630 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.02211014 |
| 129 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00481005 |
| 130 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.99786708 |
| 131 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.99393274 |
| 132 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.99358550 |
| 133 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98628719 |
| 134 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.98292315 |
| 135 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.97257023 |
| 136 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.96834219 |
| 137 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.96679699 |
| 138 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96497349 |
| 139 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.95842089 |
| 140 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.95781343 |
| 141 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.95510791 |
| 142 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.94981074 |
| 143 | CJUN_26792858_Chip-Seq_BT549_Human | 0.94504195 |
| 144 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.94272799 |
| 145 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.93888554 |
| 146 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93844870 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93453886 |
| 148 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.92809032 |
| 149 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.92610802 |
| 150 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.92484124 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92142148 |
| 152 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.91922481 |
| 153 | MYB_26560356_Chip-Seq_TH1_Human | 0.91523939 |
| 154 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.91434877 |
| 155 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.90806709 |
| 156 | TP53_16413492_ChIP-PET_HCT116_Human | 0.90751146 |
| 157 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.90503308 |
| 158 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90498220 |
| 159 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.89548891 |
| 160 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.87699172 |
| 161 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87688597 |
| 162 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86954312 |
| 163 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86196039 |
| 164 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.84879426 |
| 165 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.82035350 |
| 166 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.81365928 |
| 167 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.81271323 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000920_abnormal_myelination | 5.11305454 |
| 2 | MP0003950_abnormal_plasma_membrane | 3.65996278 |
| 3 | MP0003690_abnormal_glial_cell | 3.03133688 |
| 4 | MP0002009_preneoplasia | 2.86484331 |
| 5 | MP0005171_absent_coat_pigmentation | 2.71743809 |
| 6 | MP0008260_abnormal_autophagy | 2.71589028 |
| 7 | MP0005058_abnormal_lysosome_morphology | 2.66309388 |
| 8 | MP0003724_increased_susceptibility_to | 2.65457825 |
| 9 | MP0003300_gastrointestinal_ulcer | 2.64510095 |
| 10 | MP0006082_CNS_inflammation | 2.63894143 |
| 11 | MP0003880_abnormal_central_pattern | 2.63375563 |
| 12 | MP0001905_abnormal_dopamine_level | 2.51549759 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.50621457 |
| 14 | MP0003806_abnormal_nucleotide_metabolis | 2.48047337 |
| 15 | MP0003136_yellow_coat_color | 2.43852896 |
| 16 | MP0003195_calcinosis | 2.27899084 |
| 17 | MP0008057_abnormal_DNA_replication | 2.26664936 |
| 18 | MP0003329_amyloid_beta_deposits | 2.25330481 |
| 19 | MP0002006_tumorigenesis | 2.22457576 |
| 20 | MP0004264_abnormal_extraembryonic_tissu | 2.19474814 |
| 21 | MP0004147_increased_porphyrin_level | 2.05066928 |
| 22 | MP0008438_abnormal_cutaneous_collagen | 2.03504861 |
| 23 | MP0004043_abnormal_pH_regulation | 2.01470659 |
| 24 | MP0004742_abnormal_vestibular_system | 1.97538408 |
| 25 | MP0009697_abnormal_copulation | 1.95682008 |
| 26 | MP0010352_gastrointestinal_tract_polyps | 1.90831901 |
| 27 | MP0000569_abnormal_digit_pigmentation | 1.90391306 |
| 28 | MP0002877_abnormal_melanocyte_morpholog | 1.89782647 |
| 29 | MP0003252_abnormal_bile_duct | 1.85405837 |
| 30 | MP0004381_abnormal_hair_follicle | 1.82878206 |
| 31 | MP0004270_analgesia | 1.80708823 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.80449708 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 1.79254312 |
| 34 | MP0005408_hypopigmentation | 1.78001162 |
| 35 | MP0001529_abnormal_vocalization | 1.77702324 |
| 36 | MP0005451_abnormal_body_composition | 1.77408203 |
| 37 | MP0005023_abnormal_wound_healing | 1.76419625 |
| 38 | MP0009785_altered_susceptibility_to | 1.74141664 |
| 39 | MP0005076_abnormal_cell_differentiation | 1.74044208 |
| 40 | MP0000383_abnormal_hair_follicle | 1.73404064 |
| 41 | MP0000604_amyloidosis | 1.72141835 |
| 42 | MP0003634_abnormal_glial_cell | 1.71386592 |
| 43 | MP0003191_abnormal_cellular_cholesterol | 1.68520683 |
| 44 | MP0004883_abnormal_blood_vessel | 1.68074327 |
| 45 | MP0005670_abnormal_white_adipose | 1.67236185 |
| 46 | MP0005409_darkened_coat_color | 1.66908744 |
| 47 | MP0005187_abnormal_penis_morphology | 1.63575726 |
| 48 | MP0010678_abnormal_skin_adnexa | 1.60880841 |
| 49 | MP0001851_eye_inflammation | 1.57917573 |
| 50 | MP0005083_abnormal_biliary_tract | 1.57150185 |
| 51 | MP0003828_pulmonary_edema | 1.57093960 |
| 52 | MP0003632_abnormal_nervous_system | 1.56644742 |
| 53 | MP0004142_abnormal_muscle_tone | 1.55711622 |
| 54 | MP0003436_decreased_susceptibility_to | 1.54516073 |
| 55 | MP0004885_abnormal_endolymph | 1.51122051 |
| 56 | MP0003091_abnormal_cell_migration | 1.50400765 |
| 57 | MP0002419_abnormal_innate_immunity | 1.46414023 |
| 58 | MP0004808_abnormal_hematopoietic_stem | 1.45175687 |
| 59 | MP0003045_fibrosis | 1.36628012 |
| 60 | MP0002295_abnormal_pulmonary_circulatio | 1.36318723 |
| 61 | MP0000685_abnormal_immune_system | 1.35687789 |
| 62 | MP0000566_synostosis | 1.33809498 |
| 63 | MP0002272_abnormal_nervous_system | 1.31981304 |
| 64 | MP0003186_abnormal_redox_activity | 1.31798517 |
| 65 | MP0002229_neurodegeneration | 1.28799996 |
| 66 | MP0000343_altered_response_to | 1.27994554 |
| 67 | MP0002396_abnormal_hematopoietic_system | 1.27610190 |
| 68 | MP0004272_abnormal_basement_membrane | 1.25834050 |
| 69 | MP0001800_abnormal_humoral_immune | 1.24504682 |
| 70 | MP0001545_abnormal_hematopoietic_system | 1.24298814 |
| 71 | MP0005397_hematopoietic_system_phenotyp | 1.24298814 |
| 72 | MP0001873_stomach_inflammation | 1.23205082 |
| 73 | MP0001486_abnormal_startle_reflex | 1.22634438 |
| 74 | MP0009278_abnormal_bone_marrow | 1.21976542 |
| 75 | MP0005000_abnormal_immune_tolerance | 1.21749250 |
| 76 | MP0008875_abnormal_xenobiotic_pharmacok | 1.21167489 |
| 77 | MP0001661_extended_life_span | 1.20843608 |
| 78 | MP0002064_seizures | 1.19600094 |
| 79 | MP0001542_abnormal_bone_strength | 1.19556227 |
| 80 | MP0004947_skin_inflammation | 1.19483136 |
| 81 | MP0002405_respiratory_system_inflammati | 1.17536238 |
| 82 | MP0005164_abnormal_response_to | 1.17270917 |
| 83 | MP0001845_abnormal_inflammatory_respons | 1.14812123 |
| 84 | MP0003631_nervous_system_phenotype | 1.14687041 |
| 85 | MP0003656_abnormal_erythrocyte_physiolo | 1.13203701 |
| 86 | MP0002928_abnormal_bile_duct | 1.13164809 |
| 87 | MP0005025_abnormal_response_to | 1.11435550 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 1.10996483 |
| 89 | MP0002060_abnormal_skin_morphology | 1.10579993 |
| 90 | MP0000465_gastrointestinal_hemorrhage | 1.10202351 |
| 91 | MP0002168_other_aberrant_phenotype | 1.09771585 |
| 92 | MP0001485_abnormal_pinna_reflex | 1.09273282 |
| 93 | MP0001188_hyperpigmentation | 1.07763916 |
| 94 | MP0005671_abnormal_response_to | 1.07668170 |
| 95 | MP0000015_abnormal_ear_pigmentation | 1.06014783 |
| 96 | MP0010155_abnormal_intestine_physiology | 1.05240921 |
| 97 | MP0005410_abnormal_fertilization | 1.04534484 |
| 98 | MP0000371_diluted_coat_color | 1.04256208 |
| 99 | MP0002933_joint_inflammation | 1.04127786 |
| 100 | MP0001533_abnormal_skeleton_physiology | 1.03782751 |
| 101 | MP0000372_irregular_coat_pigmentation | 1.03272477 |
| 102 | MP0009840_abnormal_foam_cell | 1.02985504 |
| 103 | MP0001835_abnormal_antigen_presentation | 1.02708888 |
| 104 | MP0002138_abnormal_hepatobiliary_system | 1.02534542 |
| 105 | MP0001958_emphysema | 1.01571269 |
| 106 | MP0001346_abnormal_lacrimal_gland | 1.00681347 |
| 107 | MP0006054_spinal_hemorrhage | 0.99087278 |
| 108 | MP0000858_altered_metastatic_potential | 0.96839647 |
| 109 | MP0003763_abnormal_thymus_physiology | 0.96664380 |
| 110 | MP0001853_heart_inflammation | 0.95214400 |
| 111 | MP0002132_abnormal_respiratory_system | 0.95186562 |
| 112 | MP0000627_abnormal_mammary_gland | 0.94589563 |
| 113 | MP0001790_abnormal_immune_system | 0.94308214 |
| 114 | MP0005387_immune_system_phenotype | 0.94308214 |
| 115 | MP0000427_abnormal_hair_cycle | 0.94166651 |
| 116 | MP0003633_abnormal_nervous_system | 0.94070504 |
| 117 | MP0005464_abnormal_platelet_physiology | 0.93218231 |
| 118 | MP0005275_abnormal_skin_tensile | 0.92065253 |
| 119 | MP0003866_abnormal_defecation | 0.91639935 |
| 120 | MP0003448_altered_tumor_morphology | 0.90837003 |
| 121 | MP0003075_altered_response_to | 0.89473346 |
| 122 | MP0003943_abnormal_hepatobiliary_system | 0.89367445 |
| 123 | MP0002420_abnormal_adaptive_immunity | 0.88479996 |
| 124 | MP0001819_abnormal_immune_cell | 0.88120517 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.87183185 |
| 126 | MP0002723_abnormal_immune_serum | 0.86860408 |
| 127 | MP0002876_abnormal_thyroid_physiology | 0.86536082 |
| 128 | MP0001440_abnormal_grooming_behavior | 0.85565893 |
| 129 | MP0009765_abnormal_xenobiotic_induced | 0.85532955 |
| 130 | MP0002098_abnormal_vibrissa_morphology | 0.84447682 |
| 131 | MP0005085_abnormal_gallbladder_physiolo | 0.83725690 |
| 132 | MP0005075_abnormal_melanosome_morpholog | 0.83503470 |
| 133 | MP0000647_abnormal_sebaceous_gland | 0.81416910 |
| 134 | MP0001879_abnormal_lymphatic_vessel | 0.81175553 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.79929997 |
| 136 | MP0005332_abnormal_amino_acid | 0.79424133 |
| 137 | MP0003172_abnormal_lysosome_physiology | 0.79047905 |
| 138 | MP0005376_homeostasis/metabolism_phenot | 0.78960488 |
| 139 | MP0000249_abnormal_blood_vessel | 0.78854908 |
| 140 | MP0005166_decreased_susceptibility_to | 0.78639896 |
| 141 | MP0003183_abnormal_peptide_metabolism | 0.78154716 |
| 142 | MP0009046_muscle_twitch | 0.78062689 |
| 143 | MP0005310_abnormal_salivary_gland | 0.77276112 |
| 144 | MP0002734_abnormal_mechanical_nocicepti | 0.76691944 |
| 145 | MP0003303_peritoneal_inflammation | 0.76661787 |
| 146 | MP0009764_decreased_sensitivity_to | 0.76427586 |
| 147 | MP0005365_abnormal_bile_salt | 0.75706583 |
| 148 | MP0004134_abnormal_chest_morphology | 0.74971009 |
| 149 | MP0003868_abnormal_feces_composition | 0.73967996 |
| 150 | MP0002896_abnormal_bone_mineralization | 0.73510667 |
| 151 | MP0005388_respiratory_system_phenotype | 0.73391477 |
| 152 | MP0002133_abnormal_respiratory_system | 0.73391477 |
| 153 | MP0001963_abnormal_hearing_physiology | 0.73103408 |
| 154 | MP0001501_abnormal_sleep_pattern | 0.72906469 |
| 155 | MP0005390_skeleton_phenotype | 0.72560019 |
| 156 | MP0001756_abnormal_urination | 0.72068722 |
| 157 | MP0001666_abnormal_nutrient_absorption | 0.71873347 |
| 158 | MP0009333_abnormal_splenocyte_physiolog | 0.71700562 |
| 159 | MP0009780_abnormal_chondrocyte_physiolo | 0.71645724 |
| 160 | MP0001243_abnormal_dermal_layer | 0.71056495 |
| 161 | MP0009745_abnormal_behavioral_response | 0.70866929 |
| 162 | MP0008469_abnormal_protein_level | 0.70532785 |
| 163 | MP0000778_abnormal_nervous_system | 0.68315208 |
| 164 | MP0001664_abnormal_digestion | 0.67940998 |
| 165 | MP0002998_abnormal_bone_remodeling | 0.66736243 |
| 166 | MP0001177_atelectasis | 0.65581849 |
| 167 | MP0003718_maternal_effect | 0.65377013 |
| 168 | MP0002452_abnormal_antigen_presenting | 0.64847713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 5.24038035 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 5.24038035 |
| 3 | Neurofibrillary tangles (HP:0002185) | 4.93208865 |
| 4 | Parakeratosis (HP:0001036) | 4.70989829 |
| 5 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.41726225 |
| 6 | Absent frontal sinuses (HP:0002688) | 3.94662231 |
| 7 | Sensory axonal neuropathy (HP:0003390) | 3.74590222 |
| 8 | Follicular hyperkeratosis (HP:0007502) | 3.55801752 |
| 9 | Abnormality of the nasal septum (HP:0000419) | 3.45495893 |
| 10 | Abnormality of glycolysis (HP:0004366) | 3.44287036 |
| 11 | Increased serum pyruvate (HP:0003542) | 3.44287036 |
| 12 | Alopecia of scalp (HP:0002293) | 3.40170792 |
| 13 | Abnormality of the corticospinal tract (HP:0002492) | 3.32614334 |
| 14 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.32144614 |
| 15 | Subacute progressive viral hepatitis (HP:0006572) | 3.16056988 |
| 16 | Aortic aneurysm (HP:0004942) | 3.15035737 |
| 17 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.14248280 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 3.14093782 |
| 19 | Autoamputation (HP:0001218) | 3.14036013 |
| 20 | Hepatosplenomegaly (HP:0001433) | 3.05140912 |
| 21 | Orchitis (HP:0100796) | 3.05004652 |
| 22 | Cerebral hypomyelination (HP:0006808) | 3.03692582 |
| 23 | Malnutrition (HP:0004395) | 3.01275727 |
| 24 | Scanning speech (HP:0002168) | 2.99886304 |
| 25 | Prolonged neonatal jaundice (HP:0006579) | 2.97520328 |
| 26 | Aortic dissection (HP:0002647) | 2.96729751 |
| 27 | Spinal cord lesions (HP:0100561) | 2.94913279 |
| 28 | Syringomyelia (HP:0003396) | 2.94913279 |
| 29 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.88781978 |
| 30 | Arterial tortuosity (HP:0005116) | 2.87607608 |
| 31 | Axonal loss (HP:0003447) | 2.82654707 |
| 32 | Mitral stenosis (HP:0001718) | 2.80181882 |
| 33 | Peripheral hypomyelination (HP:0007182) | 2.79781647 |
| 34 | Onion bulb formation (HP:0003383) | 2.79501162 |
| 35 | Spondylolisthesis (HP:0003302) | 2.77891730 |
| 36 | Micronodular cirrhosis (HP:0001413) | 2.77878594 |
| 37 | Stomatitis (HP:0010280) | 2.76601596 |
| 38 | Eczematoid dermatitis (HP:0000976) | 2.71634387 |
| 39 | Spastic paraparesis (HP:0002313) | 2.70371561 |
| 40 | Retrobulbar optic neuritis (HP:0100654) | 2.66180934 |
| 41 | Optic neuritis (HP:0100653) | 2.66180934 |
| 42 | Myositis (HP:0100614) | 2.65225220 |
| 43 | Sparse lateral eyebrow (HP:0005338) | 2.63665904 |
| 44 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61830540 |
| 45 | 3-Methylglutaconic aciduria (HP:0003535) | 2.61165164 |
| 46 | Vacuolated lymphocytes (HP:0001922) | 2.60354601 |
| 47 | Stridor (HP:0010307) | 2.57625036 |
| 48 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.56788712 |
| 49 | Abnormality of the frontal sinuses (HP:0002687) | 2.52349070 |
| 50 | Slow saccadic eye movements (HP:0000514) | 2.52011828 |
| 51 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.50388137 |
| 52 | Renal Fanconi syndrome (HP:0001994) | 2.48948611 |
| 53 | Abnormality of macrophages (HP:0004311) | 2.48852990 |
| 54 | J-shaped sella turcica (HP:0002680) | 2.47228370 |
| 55 | Submucous cleft hard palate (HP:0000176) | 2.46244445 |
| 56 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.43727585 |
| 57 | Cerebral hemorrhage (HP:0001342) | 2.41290759 |
| 58 | Leukodystrophy (HP:0002415) | 2.41138296 |
| 59 | Abnormal auditory evoked potentials (HP:0006958) | 2.40783582 |
| 60 | Vascular tortuosity (HP:0004948) | 2.39941729 |
| 61 | Osteolytic defects of the hand bones (HP:0009699) | 2.34163697 |
| 62 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.34163697 |
| 63 | Purpura (HP:0000979) | 2.33209168 |
| 64 | Patchy hypopigmentation of hair (HP:0011365) | 2.33167220 |
| 65 | Premature skin wrinkling (HP:0100678) | 2.29747600 |
| 66 | Asymmetry of the thorax (HP:0001555) | 2.29645542 |
| 67 | Generalized hypopigmentation of hair (HP:0011358) | 2.28866265 |
| 68 | Interstitial pulmonary disease (HP:0006530) | 2.28699235 |
| 69 | Akinesia (HP:0002304) | 2.26617622 |
| 70 | Methylmalonic acidemia (HP:0002912) | 2.24611480 |
| 71 | Autoimmune hemolytic anemia (HP:0001890) | 2.24039897 |
| 72 | Abnormality of the pericardium (HP:0001697) | 2.23035309 |
| 73 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.22752775 |
| 74 | Premature rupture of membranes (HP:0001788) | 2.22500416 |
| 75 | Metabolic alkalosis (HP:0200114) | 2.21056697 |
| 76 | Coarse hair (HP:0002208) | 2.18745858 |
| 77 | Deep philtrum (HP:0002002) | 2.18599976 |
| 78 | Clumsiness (HP:0002312) | 2.18556938 |
| 79 | White forelock (HP:0002211) | 2.18291552 |
| 80 | Ectropion (HP:0000656) | 2.17598773 |
| 81 | Mucopolysacchariduria (HP:0008155) | 2.16322222 |
| 82 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.16322222 |
| 83 | Gingivitis (HP:0000230) | 2.13239255 |
| 84 | Lip pit (HP:0100267) | 2.12895461 |
| 85 | Adrenal hypoplasia (HP:0000835) | 2.12676625 |
| 86 | Papillary thyroid carcinoma (HP:0002895) | 2.11022457 |
| 87 | Hypokalemic alkalosis (HP:0001949) | 2.10845013 |
| 88 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.09213117 |
| 89 | Stomach cancer (HP:0012126) | 2.08693105 |
| 90 | Erythroderma (HP:0001019) | 2.07432978 |
| 91 | Peritonitis (HP:0002586) | 2.05961209 |
| 92 | Supranuclear gaze palsy (HP:0000605) | 2.04239652 |
| 93 | Aneurysm (HP:0002617) | 2.03337903 |
| 94 | Paraparesis (HP:0002385) | 2.03326761 |
| 95 | Glomerulonephritis (HP:0000099) | 2.03004583 |
| 96 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.02761954 |
| 97 | CNS hypomyelination (HP:0003429) | 2.02442683 |
| 98 | Recurrent bacterial skin infections (HP:0005406) | 2.02065059 |
| 99 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.00272201 |
| 100 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.00272201 |
| 101 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.00272201 |
| 102 | Curly hair (HP:0002212) | 1.99671753 |
| 103 | Episodic fever (HP:0001954) | 1.99583240 |
| 104 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.98579496 |
| 105 | Steatorrhea (HP:0002570) | 1.98573836 |
| 106 | Hepatocellular necrosis (HP:0001404) | 1.98024814 |
| 107 | Fair hair (HP:0002286) | 1.97701204 |
| 108 | Spastic tetraparesis (HP:0001285) | 1.97215360 |
| 109 | Striae distensae (HP:0001065) | 1.95817461 |
| 110 | Spastic gait (HP:0002064) | 1.95690861 |
| 111 | Increased CSF protein (HP:0002922) | 1.95505684 |
| 112 | Recurrent abscess formation (HP:0002722) | 1.95257516 |
| 113 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.94673248 |
| 114 | Infantile muscular hypotonia (HP:0008947) | 1.94064049 |
| 115 | Thickened helices (HP:0000391) | 1.93709745 |
| 116 | Thick nail (HP:0001805) | 1.93596618 |
| 117 | Periodontitis (HP:0000704) | 1.93328399 |
| 118 | Cervical subluxation (HP:0003308) | 1.92965557 |
| 119 | Gastrointestinal infarctions (HP:0005244) | 1.92586716 |
| 120 | Intention tremor (HP:0002080) | 1.92584769 |
| 121 | Abnormality of the sella turcica (HP:0002679) | 1.91646988 |
| 122 | Cone-rod dystrophy (HP:0000548) | 1.90970028 |
| 123 | Increased cerebral lipofuscin (HP:0011813) | 1.90167976 |
| 124 | Split foot (HP:0001839) | 1.89924562 |
| 125 | Hypomagnesemia (HP:0002917) | 1.88246411 |
| 126 | Acute necrotizing encephalopathy (HP:0006965) | 1.87583664 |
| 127 | Abnormality of the common coagulation pathway (HP:0010990) | 1.86928415 |
| 128 | Mitochondrial inheritance (HP:0001427) | 1.86673023 |
| 129 | Morphological abnormality of the inner ear (HP:0011390) | 1.86233900 |
| 130 | Conical tooth (HP:0000698) | 1.85915918 |
| 131 | Abnormality of renal resorption (HP:0011038) | 1.84918183 |
| 132 | Deformed sella turcica (HP:0002681) | 1.84462038 |
| 133 | Abnormal hair whorl (HP:0010721) | 1.84096025 |
| 134 | Retinal dysplasia (HP:0007973) | 1.83800837 |
| 135 | Increased circulating renin level (HP:0000848) | 1.83510101 |
| 136 | Vascular calcification (HP:0004934) | 1.83014609 |
| 137 | Tetraparesis (HP:0002273) | 1.82956213 |
| 138 | Alacrima (HP:0000522) | 1.82806473 |
| 139 | Hypophosphatemic rickets (HP:0004912) | 1.80994174 |
| 140 | Keratitis (HP:0000491) | 1.79394282 |
| 141 | Dysmetria (HP:0001310) | 1.79273044 |
| 142 | Recurrent skin infections (HP:0001581) | 1.78483381 |
| 143 | Pulmonary infiltrates (HP:0002113) | 1.78287615 |
| 144 | Amelogenesis imperfecta (HP:0000705) | 1.78273452 |
| 145 | Albinism (HP:0001022) | 1.77788499 |
| 146 | Aortic regurgitation (HP:0001659) | 1.77775193 |
| 147 | Abnormality of the axillary hair (HP:0100134) | 1.77235269 |
| 148 | Abnormality of secondary sexual hair (HP:0009888) | 1.77235269 |
| 149 | Abnormality of T cell number (HP:0011839) | 1.77135054 |
| 150 | Ileus (HP:0002595) | 1.76838978 |
| 151 | Hyperkalemia (HP:0002153) | 1.76358976 |
| 152 | Anhidrosis (HP:0000970) | 1.75792814 |
| 153 | Cupped ear (HP:0000378) | 1.74848934 |
| 154 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.73793148 |
| 155 | Right ventricular cardiomyopathy (HP:0011663) | 1.73390621 |
| 156 | Poor speech (HP:0002465) | 1.73268434 |
| 157 | Acute myeloid leukemia (HP:0004808) | 1.73197872 |
| 158 | Hemorrhage of the eye (HP:0011885) | 1.71913181 |
| 159 | Diminished movement (HP:0002374) | 1.71441565 |
| 160 | Neuroendocrine neoplasm (HP:0100634) | 1.71010221 |
| 161 | Progressive neurologic deterioration (HP:0002344) | 1.70902006 |
| 162 | Barrel-shaped chest (HP:0001552) | 1.70363090 |
| 163 | Muscle fiber splitting (HP:0003555) | 1.70228242 |
| 164 | Autoimmune thrombocytopenia (HP:0001973) | 1.69620562 |
| 165 | Opisthotonus (HP:0002179) | 1.69551313 |
| 166 | Abnormality of the umbilical cord (HP:0010881) | 1.69250502 |
| 167 | Intrahepatic cholestasis (HP:0001406) | 1.69053428 |
| 168 | Mediastinal lymphadenopathy (HP:0100721) | 1.68433631 |
| 169 | Abolished electroretinogram (ERG) (HP:0000550) | 1.68142906 |
| 170 | Synostosis involving the elbow (HP:0003938) | 1.68013033 |
| 171 | Humeroradial synostosis (HP:0003041) | 1.68013033 |
| 172 | Viral hepatitis (HP:0006562) | 1.67601123 |
| 173 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.67409323 |
| 174 | Narrow palate (HP:0000189) | 1.66814155 |
| 175 | Amyloidosis (HP:0011034) | 1.66658862 |
| 176 | Cardiovascular calcification (HP:0011915) | 1.66044610 |
| 177 | Hypoplasia of the iris (HP:0007676) | 1.65830415 |
| 178 | Nonprogressive disorder (HP:0003680) | 1.65646424 |
| 179 | Alveolar cell carcinoma (HP:0006519) | 1.65425439 |
| 180 | Cerebral aneurysm (HP:0004944) | 1.64152890 |
| 181 | Acute encephalopathy (HP:0006846) | 1.62804288 |
| 182 | Keratoconjunctivitis sicca (HP:0001097) | 1.62665136 |
| 183 | Cheilitis (HP:0100825) | 1.61765334 |
| 184 | Large for gestational age (HP:0001520) | 1.60767920 |
| 185 | Hemoptysis (HP:0002105) | 1.59475438 |
| 186 | Osteomyelitis (HP:0002754) | 1.58787037 |
| 187 | Chronic diarrhea (HP:0002028) | 1.58574407 |
| 188 | Myocardial infarction (HP:0001658) | 1.58134939 |
| 189 | Gingival bleeding (HP:0000225) | 1.58107629 |
| 190 | Keratoconjunctivitis (HP:0001096) | 1.57993705 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 5.33773252 |
| 2 | OXSR1 | 4.51014265 |
| 3 | FRK | 3.47169004 |
| 4 | PBK | 3.17855460 |
| 5 | MST1R | 3.11434427 |
| 6 | MST4 | 2.72683875 |
| 7 | EPHB1 | 2.69422835 |
| 8 | BCR | 2.55639710 |
| 9 | MAPKAPK5 | 2.52545937 |
| 10 | CDK19 | 2.33455545 |
| 11 | CASK | 2.29712826 |
| 12 | MET | 2.00208493 |
| 13 | PKN1 | 1.99180080 |
| 14 | NEK6 | 1.98123818 |
| 15 | MAP3K2 | 1.84289338 |
| 16 | TYK2 | 1.80402851 |
| 17 | CSNK1G3 | 1.78933434 |
| 18 | MAP3K3 | 1.78905303 |
| 19 | LIMK1 | 1.76525771 |
| 20 | WNK4 | 1.76449807 |
| 21 | FER | 1.72107994 |
| 22 | JAK1 | 1.69760762 |
| 23 | BMPR1B | 1.65600247 |
| 24 | CSNK1A1L | 1.65100473 |
| 25 | MAP3K14 | 1.60240004 |
| 26 | MUSK | 1.57921398 |
| 27 | ERN1 | 1.55998810 |
| 28 | FGFR2 | 1.50145141 |
| 29 | ACVR1B | 1.49826654 |
| 30 | TESK2 | 1.49069061 |
| 31 | BMPR2 | 1.48595804 |
| 32 | SCYL2 | 1.44251011 |
| 33 | CSNK1G1 | 1.40614851 |
| 34 | CAMK2B | 1.36175376 |
| 35 | FGFR3 | 1.35949373 |
| 36 | TXK | 1.31612145 |
| 37 | CDK6 | 1.31299187 |
| 38 | TRPM7 | 1.30560608 |
| 39 | WNK1 | 1.30468338 |
| 40 | FGR | 1.29693200 |
| 41 | BRSK2 | 1.27716094 |
| 42 | PRPF4B | 1.24187642 |
| 43 | CSNK1G2 | 1.20421775 |
| 44 | TGFBR2 | 1.17958473 |
| 45 | EPHA3 | 1.17501491 |
| 46 | CLK1 | 1.16424439 |
| 47 | TNIK | 1.16333639 |
| 48 | TAOK3 | 1.15389855 |
| 49 | INSRR | 1.14828414 |
| 50 | SGK223 | 1.13428011 |
| 51 | SGK494 | 1.13428011 |
| 52 | FGFR4 | 1.11789135 |
| 53 | CHUK | 1.09774012 |
| 54 | IRAK3 | 1.08309940 |
| 55 | PDGFRB | 1.08211766 |
| 56 | CAMK2D | 1.06933242 |
| 57 | EIF2AK3 | 1.06685037 |
| 58 | SIK1 | 1.04000229 |
| 59 | ERBB4 | 1.03321047 |
| 60 | AKT3 | 1.00577767 |
| 61 | MKNK1 | 0.99177300 |
| 62 | RPS6KB2 | 0.97890623 |
| 63 | LMTK2 | 0.96024584 |
| 64 | PIK3CA | 0.94894965 |
| 65 | STK38L | 0.93899389 |
| 66 | CAMK2G | 0.93183210 |
| 67 | MAPKAPK3 | 0.93045327 |
| 68 | ROCK2 | 0.91251835 |
| 69 | MAPK11 | 0.88353179 |
| 70 | PRKCQ | 0.86948498 |
| 71 | NEK9 | 0.85763070 |
| 72 | PRKCE | 0.85138011 |
| 73 | CDC42BPA | 0.82867954 |
| 74 | RPS6KA5 | 0.80790165 |
| 75 | IKBKE | 0.79406629 |
| 76 | PTK2 | 0.78957387 |
| 77 | ARAF | 0.78812983 |
| 78 | EPHA2 | 0.78786796 |
| 79 | JAK2 | 0.77050467 |
| 80 | IKBKB | 0.76831049 |
| 81 | PKN2 | 0.76283963 |
| 82 | ZAP70 | 0.76125203 |
| 83 | ADRBK2 | 0.76088461 |
| 84 | HIPK2 | 0.73067639 |
| 85 | PAK4 | 0.73003279 |
| 86 | PIM2 | 0.72702640 |
| 87 | NLK | 0.70590094 |
| 88 | STK38 | 0.70086149 |
| 89 | PLK2 | 0.69532507 |
| 90 | RIPK4 | 0.69329295 |
| 91 | IRAK4 | 0.67746648 |
| 92 | STK16 | 0.67630319 |
| 93 | GRK7 | 0.67502233 |
| 94 | CAMK2A | 0.67442712 |
| 95 | EIF2AK1 | 0.66583787 |
| 96 | MAP3K12 | 0.65180240 |
| 97 | MAP2K3 | 0.61877199 |
| 98 | JAK3 | 0.61693324 |
| 99 | NTRK1 | 0.61366144 |
| 100 | NUAK1 | 0.60543851 |
| 101 | PIK3CG | 0.60515592 |
| 102 | STK3 | 0.59057996 |
| 103 | MTOR | 0.59054325 |
| 104 | BRD4 | 0.58068074 |
| 105 | ERBB3 | 0.57796212 |
| 106 | MAP2K1 | 0.57158613 |
| 107 | MAPKAPK2 | 0.56325213 |
| 108 | HCK | 0.56251680 |
| 109 | SIK3 | 0.55701339 |
| 110 | PDGFRA | 0.54839484 |
| 111 | PDPK1 | 0.53656975 |
| 112 | PDK2 | 0.53443563 |
| 113 | CDK12 | 0.53427907 |
| 114 | MYLK | 0.52604743 |
| 115 | PDK1 | 0.51967537 |
| 116 | ABL1 | 0.51566640 |
| 117 | MAP3K1 | 0.51293224 |
| 118 | NME1 | 0.51203544 |
| 119 | BUB1 | 0.51114740 |
| 120 | ADRBK1 | 0.51009125 |
| 121 | FGFR1 | 0.50828820 |
| 122 | MAP3K7 | 0.50646875 |
| 123 | PAK2 | 0.48849989 |
| 124 | MAPK7 | 0.48444014 |
| 125 | STK10 | 0.48204848 |
| 126 | MAP3K13 | 0.48182753 |
| 127 | EPHA4 | 0.47738349 |
| 128 | GRK1 | 0.47524638 |
| 129 | LCK | 0.45182465 |
| 130 | KIT | 0.44399309 |
| 131 | CSNK1A1 | 0.44234180 |
| 132 | PTK6 | 0.43238684 |
| 133 | STK24 | 0.41404142 |
| 134 | PRKG1 | 0.41147942 |
| 135 | DYRK2 | 0.40116444 |
| 136 | SGK2 | 0.39988773 |
| 137 | TTN | 0.39670592 |
| 138 | IRAK1 | 0.39364754 |
| 139 | SGK3 | 0.38960413 |
| 140 | TEC | 0.38753913 |
| 141 | FYN | 0.37193343 |
| 142 | PAK3 | 0.36969925 |
| 143 | DAPK3 | 0.36124685 |
| 144 | CDK14 | 0.35600294 |
| 145 | TBK1 | 0.35138771 |
| 146 | YES1 | 0.35011484 |
| 147 | CSK | 0.34271533 |
| 148 | ZAK | 0.34268794 |
| 149 | PTK2B | 0.33116263 |
| 150 | PRKCD | 0.32802777 |
| 151 | PRKACB | 0.31850271 |
| 152 | CDK5 | 0.31731788 |
| 153 | GSK3A | 0.31594294 |
| 154 | ITK | 0.30747270 |
| 155 | ABL2 | 0.30353458 |
| 156 | UHMK1 | 0.30343506 |
| 157 | BLK | 0.30101479 |
| 158 | CSF1R | 0.29841347 |
| 159 | MELK | 0.29765018 |
| 160 | IRAK2 | 0.28647526 |
| 161 | VRK1 | 0.28179302 |
| 162 | STK4 | 0.25649148 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Steroid biosynthesis_Homo sapiens_hsa00100 | 4.26283752 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.23884339 |
| 3 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.04322740 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.13209984 |
| 5 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 2.98811877 |
| 6 | Protein export_Homo sapiens_hsa03060 | 2.89735162 |
| 7 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.67922444 |
| 8 | Ether lipid metabolism_Homo sapiens_hsa00565 | 2.45992540 |
| 9 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.37892980 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.35902532 |
| 11 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.14083122 |
| 12 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.09743875 |
| 13 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.05511864 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.00224040 |
| 15 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.96119874 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.81383843 |
| 17 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.77797658 |
| 18 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.74597224 |
| 19 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.73718091 |
| 20 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.71696429 |
| 21 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.66093277 |
| 22 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.65975651 |
| 23 | Malaria_Homo sapiens_hsa05144 | 1.61019404 |
| 24 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58111028 |
| 25 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.51792248 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.51442200 |
| 27 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.51255586 |
| 28 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.47700236 |
| 29 | Measles_Homo sapiens_hsa05162 | 1.44501855 |
| 30 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.41909740 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.39338526 |
| 32 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.37131772 |
| 33 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.36915732 |
| 34 | Influenza A_Homo sapiens_hsa05164 | 1.35179824 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.34332926 |
| 36 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.34330158 |
| 37 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.34157027 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.31917571 |
| 39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.31112363 |
| 40 | Insulin resistance_Homo sapiens_hsa04931 | 1.30606242 |
| 41 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.29637558 |
| 42 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.27960560 |
| 43 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.27477901 |
| 44 | Lysosome_Homo sapiens_hsa04142 | 1.26658962 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 1.25612085 |
| 46 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.23155958 |
| 47 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.22682527 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.21765104 |
| 49 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.19747138 |
| 50 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19687497 |
| 51 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.19293632 |
| 52 | Prostate cancer_Homo sapiens_hsa05215 | 1.18305070 |
| 53 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.17507923 |
| 54 | ABC transporters_Homo sapiens_hsa02010 | 1.16192571 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.16118148 |
| 56 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.14684387 |
| 57 | Proteasome_Homo sapiens_hsa03050 | 1.13828594 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.12280759 |
| 59 | Parkinsons disease_Homo sapiens_hsa05012 | 1.10454908 |
| 60 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10102079 |
| 61 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.09154742 |
| 62 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.08082536 |
| 63 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.07747489 |
| 64 | Alzheimers disease_Homo sapiens_hsa05010 | 1.05872079 |
| 65 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.05302614 |
| 66 | Adherens junction_Homo sapiens_hsa04520 | 1.04629586 |
| 67 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.03094382 |
| 68 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.01734844 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.01336384 |
| 70 | Asthma_Homo sapiens_hsa05310 | 1.01236037 |
| 71 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.00631382 |
| 72 | Peroxisome_Homo sapiens_hsa04146 | 0.98464687 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.96363056 |
| 74 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.96228283 |
| 75 | Focal adhesion_Homo sapiens_hsa04510 | 0.95572009 |
| 76 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.95556986 |
| 77 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.93817831 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.91934710 |
| 79 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.90760002 |
| 80 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.89923497 |
| 81 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.89276679 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.87267436 |
| 83 | Apoptosis_Homo sapiens_hsa04210 | 0.86617027 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86005055 |
| 85 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.84657742 |
| 86 | Circadian rhythm_Homo sapiens_hsa04710 | 0.83180899 |
| 87 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.82913940 |
| 88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.81781063 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.77892273 |
| 90 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77326853 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.76942560 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76853126 |
| 93 | Thyroid cancer_Homo sapiens_hsa05216 | 0.76750894 |
| 94 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.76097389 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.75988328 |
| 96 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74789497 |
| 97 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74481640 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.73416363 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.73330551 |
| 100 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73182255 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71697763 |
| 102 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.71114116 |
| 103 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70867258 |
| 104 | Mineral absorption_Homo sapiens_hsa04978 | 0.69822066 |
| 105 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.69648115 |
| 106 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68584700 |
| 107 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.68547145 |
| 108 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.68212177 |
| 109 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68077016 |
| 110 | Endometrial cancer_Homo sapiens_hsa05213 | 0.64551857 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.64143318 |
| 112 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.63911031 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.63004437 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62876861 |
| 115 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.62585894 |
| 116 | Other glycan degradation_Homo sapiens_hsa00511 | 0.60760707 |
| 117 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60581159 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.59920136 |
| 119 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.59084408 |
| 120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.58999161 |
| 121 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58437331 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56515243 |
| 123 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.55991823 |
| 124 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.55217760 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.54788167 |
| 126 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.54083164 |
| 127 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53829218 |
| 128 | RNA polymerase_Homo sapiens_hsa03020 | 0.53411271 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.53108146 |
| 130 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.52305753 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.51687322 |
| 132 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50978197 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.49125051 |
| 134 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.47962943 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.47011039 |
| 136 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46868145 |
| 137 | Axon guidance_Homo sapiens_hsa04360 | 0.45898410 |
| 138 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.45581457 |
| 139 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44763750 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.44093261 |
| 141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.43909992 |
| 142 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.43156568 |
| 143 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.42795945 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.40810608 |
| 145 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.39134992 |
| 146 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38708488 |
| 147 | Shigellosis_Homo sapiens_hsa05131 | 0.38641077 |
| 148 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37092325 |
| 149 | Hepatitis C_Homo sapiens_hsa05160 | 0.31314050 |
| 150 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.30142748 |
| 151 | Endocytosis_Homo sapiens_hsa04144 | 0.29662140 |
| 152 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28671185 |
| 153 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27788642 |
| 154 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.27109098 |
| 155 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.27066860 |
| 156 | Tuberculosis_Homo sapiens_hsa05152 | 0.26756780 |
| 157 | Tight junction_Homo sapiens_hsa04530 | 0.24924374 |
| 158 | Leishmaniasis_Homo sapiens_hsa05140 | 0.24886156 |
| 159 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.24809634 |
| 160 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.24494723 |
| 161 | Basal transcription factors_Homo sapiens_hsa03022 | 0.23895753 |
| 162 | Legionellosis_Homo sapiens_hsa05134 | 0.19608787 |
| 163 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.19321062 |

